These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9642487)

  • 1. Effect of lipid-lowering therapy on myocardial ischemia.
    Tzivoni D; Klein J
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():135-9. PubMed ID: 9642487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
    Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points.
    Kinlay S; Selwyn AP; Delagrange D; Creager MA; Libby P; Ganz P
    Curr Opin Lipidol; 1996 Dec; 7(6):389-97. PubMed ID: 9117144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.
    van Boven AJ; Jukema JW; Zwinderman AH; Crijns HJ; Lie KI; Bruschke AV
    Circulation; 1996 Oct; 94(7):1503-5. PubMed ID: 8840836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention.
    Fathi R; Haluska B; Short L; Marwick TH
    Am J Med; 2003 Apr; 114(6):445-53. PubMed ID: 12727577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of reduced cholesterol on coronary arteries].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 1998 Oct; 118(24):3805-9. PubMed ID: 9816952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.
    Gould KL
    Am J Med; 1998 Jun; 104(6A):2S-17S. PubMed ID: 9684847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease.
    Andrews TC; Raby K; Barry J; Naimi CL; Allred E; Ganz P; Selwyn AP
    Circulation; 1997 Jan; 95(2):324-8. PubMed ID: 9008444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Schwartz GG; Oliver MF; Ezekowitz MD; Ganz P; Waters D; Kane JP; Texter M; Pressler ML; Black D; Chaitman BR; Olsson AG
    Am J Cardiol; 1998 Mar; 81(5):578-81. PubMed ID: 9514453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients].
    Semenova AE; Sergienko IV; Masenko VP; Gabrusenko SA; Kukharchuk VV; Belenkov IuN
    Kardiologiia; 2007; 47(11):4-8. PubMed ID: 18260956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
    Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP
    Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
    Waters DD; Schwartz GG; Olsson AG; Zeiher A; Oliver MF; Ganz P; Ezekowitz M; Chaitman BR; Leslie SJ; Stern T;
    Circulation; 2002 Sep; 106(13):1690-5. PubMed ID: 12270864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering.
    Bonetti PO; Wilson SH; Rodriguez-Porcel M; Holmes DR; Lerman LO; Lerman A
    J Am Coll Cardiol; 2002 Aug; 40(3):546-54. PubMed ID: 12142124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania PC;
    Am Heart J; 2004 Dec; 148(6):1053-9. PubMed ID: 15632893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of cholesterol-lowering therapy: coronary angiographic and events trials.
    Waters D; Pedersen TR
    Am J Med; 1996 Oct; 101(4A):4A34S-38S; discussion 39S. PubMed ID: 8900335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
    Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
    Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
    Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.